“…Ulmsten and Petros ¢rst introduced the TVT Neurourology and Urodynamics DOI 10.1002/nau Kuuva and Nilsson [2002] 1,455 patientsTVT 24/367 6 transfusion/signif bleed (0.4%), 11 bladder perforations (0.75%), 2 vascular injury (0.1%)1 nerve injury (0.07%), 4 abscesses (0.2%) Hong et al [2003] 375 patients, TVT 5/143 1 nerve injury (0.3%), 4 hematoma (1.1%) Kobashi and Govier [2003] 140 patients, SPARC 6/6 4 transfusions (2.8%), 1 bowel perforation (0.7%), 1 hematoma (0.7%) Karram et al [2003] 350 patients, TVT 6/97 2 hematoma (0.9%), 3 nerve injury (0.9%), 1urethral erosion (0.3%) Abouassaly et al [2004] 241 patients, TVT 7/173 6 signi¢cance bleed >500 ml (2.5%), 1 hematoma (0.4%) Levin et al [2004] 313 patients, TVT 2/67 2 unrecognized blad perf (0.6%) Wang [2004] 600 patients, TVT 0/28 Tsivian et al [2004] 200 patients, TVT 1/25 1 unrecognized blad perf (0.5%) Hodro¡ et al [2005] 445 patients, SPARC 2/82 1 bowel perforation (0.2%), 1 rectus hematoma (0.2%) Hammad et al [2005] 1,459 patients, TVT 993, SPARC 466 2/121 2 urethral erosion (0.1%) Paick et al [2005] 274 patients, TVT 0/110 De Leval [2003] 107 patients, TO generic (inside-out) 0/7 Delorme et al [2004] 32 patients, Uratape 0/8 DeTayrac et al [2004] 30 patients, Uratape 1/8 1 obturator hematoma (3%) Costa et al [2004] 183 patients, Uratape 2/20 2 urethral erosion (1%) Mellier et al [2004] 94 patients, Monarc 0/3 Domingo et al [2005] 65 patients, Uratape 43, Obtape 21 1/10 1 obturator abscess (1.5%) Fischer et al [2005] 220 patients, Monarc, Serasis-TO 0/18 Spinosa and Dubuis [2005] 117 patients, ObTape 0/10 Naidu et al [2005] 96 patients, Monarc 0/12 Siegel [2005] 30 patients, ObTape 1/6 1 obturator abscess (3%) Palma et al [2005] 100 patients, SAFYRE 0/20 Krauth et al [2005] 604 patients, I-STOP 1/60 1 signi¢cant bleed (0.2%) Davila et al [2005] 200 patients, Monarc 0/13 Roumeguere et al [2005] 120 patients, Uratape 60, Obtape 60 2/38 2 unrecognized urethra inj (1.7%)…”